Table1_Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis.DOCX
Background<p>Abraxane plays a crucial role in the treatment of various types of cancer, despite the considerable attention it has garnered for its adverse drug events (ADEs). Nevertheless, there is currently a significant lack of comprehensive real-world pharmacovigilance studies on the ADEs a...
Saved in:
| Main Author: | Yuanqiong Duan (16022084) (author) |
|---|---|
| Other Authors: | Ying Wang (11406) (author), Shentao Lu (19956195) (author), Mei Zeng (293866) (author), Lubin Liu (17619118) (author), Qian Dai (2640862) (author), Rutie Yin (12077955) (author) |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Table2_Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis.DOCX
by: Yuanqiong Duan (16022084)
Published: (2024) -
Table3_Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis.DOCX
by: Yuanqiong Duan (16022084)
Published: (2024) -
DataSheet1_Interstitial lung disease associated with ALK inhibitors and risk factors: an updated comparative pharmacovigilance analysis.docx
by: Junli Dong (19748755)
Published: (2024) -
Table1_Drug-induced retinal vein occlusion: a disproportionality analysis from the FDA adverse event reporting system (2004–2023).docx
by: Xiao-Dong Chen (723918)
Published: (2024) -
Table1_A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system.DOCX
by: Yu Zhang (12946)
Published: (2024)